Metabolic syndrome in vitiligo

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F12%3A8275" target="_blank" >RIV/00216208:11130/12:8275 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.1111/dth.12012" target="_blank" >http://dx.doi.org/10.1111/dth.12012</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Metabolic syndrome in vitiligo

Original language description

Vitiligo is an acquired, depigmenting skin disease with still unclear, multifactorial etiopathogenesis. However, there is growing evidence that vitiligo affects not only the skin but it may also be connected with metabolic abnormalities, including glucose intolerance and lipid abnormalities, all of which confirms the systemic nature of the disease. Recently, it has been shown that melanocytes, especially those found in the adipose tissue, due to their ability to decrease inflammation and oxidative damage, are capable of preventing the metabolic syndrome. The article presents updated knowledge on potential metabolic disturbances in vitiligo.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FO - Dermatology and venereology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Dermatologic Therapy

ISSN

1396-0296

e-ISSN

—

Volume of the periodical

25

Issue of the periodical within the volume

1

Country of publishing house

US - UNITED STATES

Number of pages

3

Pages from-to

"S41"-"S43"

UT code for WoS article

000312304200006

EID of the result in the Scopus database

—